Academic Journal
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir
| العنوان: | Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir |
|---|---|
| المؤلفون: | Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P |
| المساهمون: | Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P |
| سنة النشر: | 2022 |
| المجموعة: | IRIS Università degli Studi di Bologna (CRIS - Current Research Information System) |
| مصطلحات موضوعية: | Dual therapy, triple therapy, dolutegravir, lamivudine |
| الوصف: | Our study seems to confirm that dual therapy dolutegravir/ lamivudine is not associated with an increased risk of worsening inflammatory state in antiretroviral therapy–naive persons in comparison with standard triple regimens. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/35981265; info:eu-repo/semantics/altIdentifier/wos/WOS:000874079200001; volume:91; issue:4; firstpage:9; lastpage:11; numberofpages:3; journal:JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES; https://hdl.handle.net/11585/901262; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85140856874 |
| DOI: | 10.1097/QAI.0000000000003077 |
| الاتاحة: | https://hdl.handle.net/11585/901262 https://doi.org/10.1097/QAI.0000000000003077 |
| رقم الانضمام: | edsbas.996488C5 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1097/QAI.0000000000003077 |
|---|